Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Forgot your password?

Haven't registered yet?

Breaking News
News & Press: Daily Updates

Trial offers mixed view of Ebola drug ZMapp

Wednesday, October 12, 2016   (0 Comments)

A study today in the New England Journal of Medicine shows that ZMapp, the promising treatment for acute Ebola virus disease, narrowly missed the statistical threshold but demonstrated high efficacy after being used on 72 patients during the 2014 to 2016 Ebola outbreak in West Africa.


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.